Spyre Therapeutics
SYRE
#4131
Rank
HK$20.92 B
Marketcap
HK$269.63
Share price
0.06%
Change (1 day)
29.27%
Change (1 year)

Revenue for Spyre Therapeutics (SYRE)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of HK$6.91 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Spyre Therapeutics from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A-100%
2023 HK$6.91 M-61.97%
2022 HK$18.19 M-87.55%
2021 HK$0.14 B
2020 N/A
2019 N/A-100%
2018 HK$30.44 M-25.12%
2017 HK$40.65 M13.29%
2016 HK$35.88 M-23.91%
2015 HK$47.16 M
2014 N/A